John Tomaro
About John Tomaro
Title: Vice President, Clinical Operations
John Tomaro holds the position of Vice President of Clinical Operations at Bolt Biotherapeutics, a role he has been fulfilling since 2020. He brings to the position extensive experience in clinical operations, particularly in the fields of oncology, immuno-oncology, and rare disease. His expertise spans the entire spectrum of clinical studies from first-in-human trials through to Phase 3 clinical studies.
Professional Experience at Bolt Biotherapeutics
John Tomaro joined Bolt Biotherapeutics in 2020, bringing with him 18 years of experience in clinical operations. In his current role, he oversees the company's clinical operations with an emphasis on advancing novel therapies. His work primarily involves managing all phases of clinical trials, ensuring that the studies meet regulatory standards and scientific rigor.
Previous Roles: Sangamo Therapeutics, Celgene Corporation, BioMarin Pharmaceutical
Before joining Bolt Biotherapeutics, John Tomaro led clinical operations at Sangamo Therapeutics. There, he was responsible for overseeing clinical trials from inception through completion. Prior to Sangamo, Tomaro spent ten years at Celgene Corporation (now Bristol Myers Squibb), where he held roles of increasing responsibility, contributing significantly to the company's clinical operations. He also has experience working in clinical operations at BioMarin Pharmaceutical and Quintiles Transnational (now IQVIA).
Educational Background
John Tomaro received his master's degree from the University of California at Santa Cruz. He also holds a bachelor's degree from the University of North Carolina at Chapel Hill. His academic background provided a strong foundation for his career in clinical operations, equipping him with the knowledge and skills necessary for his current and past professional roles.